* Link Administration tops benchmark index after $2.48 bln
deal
* Rio Tinto drops 2%
* Tech, health stocks extend gains to third straight session
(Updates to close)
By Dhriti Garg
Dec 22 (Reuters) - Australian shares were little changed on
Wednesday with gains in technology and healthcare segments
countered by a slump in mining stocks, as worries over the
economic fallout from the Omicron coronavirus variant kept
investors on the edge.
The S&P/ASX 200 index .AXJO closed 0.1% higher at 7,364.8
points. The benchmark had gained 0.9% on Tuesday.
Australia conducted an emergency national cabinet meeting on
Wednesday where more vaccination funding was announced, as the
country reported more than 5,000 daily COVID-19 infections for
the first time during the pandemic. urn:newsml:reuters.com:*:nL4N2T70J7
A jump in coronavirus cases globally, just days before
Christmas, has led to social mobility restrictions in some
countries, threatening economic activity.
Miners .AXMM were among top losers in Australia, reversing
course to drop 0.4% as iron ore futures declined on possible
COVID-19 curbs in China. IRONORE/
Global miner BHP Group Ltd BHP.AX slid 0.8%, while rival
Rio Tinto Ltd RIO.AX fell 2%.
There's some weakness in steel manufacturing and property
prices in China again and markets are waking up to the fact that
iron ore's recent rally was going to be unsustainable, said
Mathan Somasundaram, CEO of Deep Data Analytics.
Gold stocks .AXGD eased 1%, led by a 3.7% fall in Regis
Resources Ltd RRL.AX .
Gold miner Falcon Metals FAL.AX , not part of the
sub-index, sank 37% in its market debut and was the top laggard
on the main index.
Technology stocks .AXIJ closed higher for a third day,
with share registry firm Link Administration Holdings Ltd
LNK.AX leading gains on the sub-index and on the benchmark,
surging 15% on accepting a C$3.2 billion ($2.48 billion) buyout
offer from a Canadian company. urn:newsml:reuters.com:*:nL4N2T70J3
Health sector .AXHJ rose 0.8%, led by Polynovo PNV.AX
and Pro Medicus PME.AX gaining 4.8% and 2.2%, respectively.
New Zealand's benchmark S&P/NZX 50 index .NZ50 firmed 0.07%
to 12,865.2 points, with pharmaceutical company EBOS Group
EBO.NZ leading the gains.
($1 = 1.2917 Canadian dollars)
(Reporting by Dhriti Garg in Bengaluru;
Editing by Vinay Dwivedi)
((Dhriti.Garg@thomsonreuters.com;))
((For more information on DIARIES & DATA:
U.S. earnings diary RESF/US
Wall Street Week Ahead .N/O
Global Economy Week Ahead DATA/
................................................................
For latest top breaking news across all markets NEWS1 ))